Are you the publisher? Claim or contact us about this channel

Embed this content in your HTML


Report adult content:

click to rate:

Account: (login)

More Channels

Channel Catalog

Channel Description:

Visit One News Page for Italy news from around the world, aggregated from leading sources including newswires, newspapers and broadcast media. Search millions of archived news headlines. This feed provides the Italy news headlines.

older | 1 | .... | 1015 | 1016 | (Page 1017) | 1018 | 1019 | .... | 1077 | newer

    0 0

    Nicki Minaj Takes Over Italy Streets W/ New Clothing Collabo: “I’m Shutting Down An Entire Block” Young Money’s Nicki Minaj is taking her new Diesel apparel collaboration overseas. The hip-hop star has teased fans about launching the partnership in Italy. Onika went to Instagram last night (September 18) to share a slideshow of pics and make a Milan event announcement. View this post on Instagram ITALY!!!! I’ve waited so long to […]

    The post Nicki Minaj Takes Over Italy Streets W/ New Clothing Collabo: “I’m Shutting Down An Entire Block” appeared first on Reported by SOHH 22 minutes ago.

    0 0

    Cannabis-focused CROP Infrastructure Corp. (CSE:CROP, CSE:CROP.CN, OTCMKTS:CRXPF) unveiled a milestone for its 'The Dozen' grrenhouse project in Washington - a permit meaning it can complete construction. The company has now received an updated building permit, after it revised its plans to include upgraded access roads and a new staff facility, including restroom and break-room. "The company has completed 90% of the construction of the first six (6) purpose-built proprietary greenhouses and will now complete the final construction for site approval," it said in a regulatory release on Tuesday. “Once the project is completed this will serve as our CROP SAFE production model for all our future builds across the globe," added Crop's director and chief executive Michael Yorke. "We intend to have strict replication of our growing procedures to get the best return from every square foot of growing space and the lowest cost possible for our tenants." The first phase of the build entailed site preparation and foundations for  12 purpose-built indoor  canopies encompassing a planned total area of around 44,000 square feet (sq ft). Each completed phase will be leased to licensed tenant growers along with brand licensing and the CROP SAFE Standard Operating Procedures (SOPs). The site currently allows for around 176,000 sq ft of canopy space. There will be 12 indoor growing facilities with a regional electricity rate of US$0.02/kWh and based on internal calculations provided by CROP’s expert consulting partner, should result in tenants having a cost of production of less than US$150 per pound. CROP’s primary focus is investing, constructing, owning and leasing greenhouse projects. It provides financing for land expansion, brand positioning opportunities, specialized equipment and access to approved nutrients for licensed cannabis producers in legal growing regions. In layman’s terms, CROP is structured in a similar way to a Real Estate Investment Trust (REIT) -  basically a company that owns, operates or finances income-producing real estate. Its projects include cultivation properties in California, Washington State, Nevada, Italy, Jamaica, and a joint venture on West Hollywood and San Bernardino dispensary applications. Reported by Proactive Investors 13 minutes ago.

    0 0

    Reported by 8 minutes ago.

    0 0

    Meet Steven Payne, the Englishman who bounced across the Alps – on a space hopper  Steven Payne, from Chichester, bought a space hopper on eBay and hopped 76 miles from Italy to Grenoble in Switzerland. Reported by MailOnline 4 hours ago.

    0 0

    Dublin, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The "The Worldwide Market for In Vitro Diagnostic Tests, 11th Edition" report has been added to *'s* offering.The Worldwide Market for In Vitro Diagnostic (IVD) Tests is the most essential report on the IVD industry. The report has been updated for two decades in eleven editions, keeping readers informed about developments in all areas of the IVD industry, around the world, in one volume. The 1,800-page report provides in vitro diagnostics market size estimates and projections for the entirety of the in vitro diagnostics testing market.

    While 70 percent of critical healthcare decisions are made with the aid of a clinical test, testing amounts for a small portion of total healthcare spending. Plus testing has the ability to better target therapy and lower costs. That's why there is continued interest from healthcare providers worldwide in in vitro testing products, and why the IVD industry maintains a high level of investor interest.

    In 2018, the market continues to evolve. Microbiome, Big Data, Next Generation Sequencing, AI, Robotics are among the trends shaping this market. Only a market research firm grounded with experience covering diagnostics over a long history can identify how trends will impact the market. That's why this in vitro diagnostic reporting has been utilized by top companies and industry investors.

    *Current 2018 IVD Market Estimates For Essential Segments*

    The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2023 for defined segments of the IVD market and various sub-segments, including:

    · Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal)
    · Clinical Chemistry and "Core Lab" Markets (including sub segment revenues for General Chemistries, Workstations, Analyzers Blood Gases, Urinalysis, Critical Care)
    · Point-of-Care Testing (POC), (Professional and Self-Testing, Glucose Testing, Pregnancy Tests, drugs of abuse, HIV, H. pylori, Other, OTC/Self Total, Professional POC, Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other)
    · Substance Abuse Testing
    · Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
    · Blood Banking (Grouping, Immunoassay Screens, NAT Screens)
    · Tissue-Based Testing - Histology and Cytology (Pap, ISH, IHC, HPV)
    · Infectious Disease Immunoassay Testing (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others)
    · Hematology
    · Flow Cytometry
    · Molecular Tests in Infectious Diseases (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria, TB, Others)
    · Non-Infectious Disease Immunoassay Sales by Analyte Type (Cardiac markers, Tumor markers, Diabetes/HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic drugs, Tox/Drugs of abuse, Vitamin D)
    · Coagulation Tests (Lab-Based, POC, Genetic Markers)
    · Mass Spectrometry
    · Molecular Point-Of-Care
    · Next Generation Sequencing
    · Direct-to-Consumer Testing

    The report also tracks hundreds of competitors, notes significant partnerships, distribution deals and acquisitions and defines the market share situation for the in vitro diagnostic market and competitive analysis for many segments.

    *The Future of IVD: Market Segment Projections to 2023*

    For each of the listed in vitro diagnostics market segments, 2018 in vitro diagnostics market size, 2023 projection and compound annual growth rate is provided, as well as significant in vitro diagnostic companies in the market and IVD manufacturers' product innovations. The market data is put into a context with real-world industry and medical practice trends. The Worldwide Market for In Vitro Diagnostic Tests has been called "The Bible of the IVD Industry" by customers, which include top IVD firms. Using the publisher's The Worldwide Market for In vitro Diagnostic (IVD) Tests, 11th Edition, ensures that your firm will have the perspective and data of others in the in vitro diagnostics industry, as well as of those who track and invest in the IVD industry.

    *The Global Market Regional and Country IVD Markets*

    The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers' product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included:

    · US
    · Europe
    · Germany
    · UK
    · France
    · Spain
    · Italy
    · Russia
    · Netherlands
    · Turkey
    · Poland
    · Canada
    · China
    · Japan
    · Saudi Arabia
    · Brazil
    · Eastern Europe
    · Emerging Markets
    · Rest of World

    The Worldwide Market for In Vitro Diagnostic Tests is a testament to the publisher's methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2018.

    *Superior In Vitro Diagnostic Company Profiles*

    This report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition contains hundreds of profiles of companies operating within the in vitro diagnostics industry. Top-tier IVD companies such as Roche Diagnostics, Abbott, Siemens, Beckman Coulter, bioMerieux, Qiagen and Ortho Clinical Diagnostics are discussed at great length and hundreds of smaller companies are detailed. Modest in vitro diagnostics technology growth in developed countries, stronger growth in developing countries with a simultaneous shift from a preoccupation with infectious diseases to chronic conditions, is expected. Also discussed within the report is increased privatization of healthcare services throughout the world, developed and emerging economies included and thus increased pricing pressure on all devices including in vitro diagnostics technology.

    The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that the researcher has in the in vitro diagnostic market is evident in its tiering and segmentation of companies.

    The report covers both the dominant companies in the in vitro diagnostics industry and the fast up-and-comers for a complete picture of the market. For each company, extensive, discussion of recent financial performance is provided. These IVD manufacturers' main products are detailed and any significant company strategies, partnerships and acquisitions are considered:

    · Abbott Diagnostics
    · Beckman Coulter, Inc. / Danaher
    · Becton, Dickinson and Company (BD)
    · bioMrieux Inc.
    · Bio-Rad Laboratories
    · Hologic
    · Instrumentation Laboratory (IL)
    · Ortho Clinical Diagnostics (OCD)
    · QIAGEN N.V
    · Roche Diagnostics
    · Siemens Healthineers
    · Sysmex Corporation
    · Thermo FisherScientific
    · Werfen Group S.A.
    · ERBA Diagnostics, Inc
    · DiaSorin S.p.A
    · Illumina
    · Luminex Corporation
    · Menarini Diagnostics.
    · Mindray Medical International Limited
    · Myriad Genetics
    · Perkin Elmer, Inc. (PE)
    · Quidel Corporation
    · Randox Laboratories Ltd
    · Royal Philips
    · TOSOH Corporation
    · Trinity Biotech
    · Wako Pure Chemical Industries

    *Specialist In Vitro Diagnostic Companies:*

    While these IVD manufacturers and companies focus on one segment of the in vitro diagnostic market, they can often be dominant in the market as well. They are important to watch because they can often develop products in new areas of testing and move categories.

    · Molecular Specialists
    · Test Services Specialists
    · Diabetes Specialists
    · Blood Banking Specialists
    · Point of Care Specialists
    · Prenatal Test Service Providers
    · Quality Control and Pretreatment Specialists
    · Coagulation Specialists
    · Histology and Cytology Specialists
    · Microbiology Specialists
    · IT Solutions Companies
    · CTC and Liquid Biopsy Specialists

    *Deep Understanding of In Vitro Diagnostic Market Trends*

    Published continuously for two decades, the report reflects the experience the researcher has in watching events in IVD and the emergence and reemergence of industry, technological and clinical trends.
    For instance:

    The revolution in bioinformatics is allowing clinical and traditional medical engineering to blend with components derived from the telecommunications, information and computer sciences industries. This opens new niche markets for POC test devices, which will have a positive impact on diagnostic testing.

    Getting information to care givers and patients is now not an added plus, it is a prerequisite of all lab operations. Thus the next 3-5 years will see an intensification of the healthcare industry's emphasis on informatics, wireless communications, data networking and cost/effective healthcare delivery.

    In the area of test economics, outcomes based disease management establishes guidelines and directives for patient care. This is having a significant effect on the use of new tests, which have to prove their added value to patient care. It also affects how many and which tests are recommended and thus reimbursed for a specific disease group.

    None of the above would be happening without significant forces in the in vitro diagnostics market driving them. The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition presents the trends, technologies, customer needs and major suppliers in the in vitro diagnostics market with an eye on how they are shaping the IVD industry, including the following industry trends:

    · Gene Editing and IVD
    · Next Generation Sequencing
    · Disease Trends
    · Retail Clinics
    · Direct-to-Consumer Testing
    · Lab-Developed Tests
    · Top 20 In Vitro Diagnostic Companies and Niche Players
    · Status of IVD M&As in 2018
    · Emerging Markets, Emerged Markets and "Next Wave" Emerging
    · Digital Technology, IT and Big Data
    · Europe Slight Recovery
    · State of Biomarker Discovery
    · Test Services Trend
    · Distribution Agreements
    · Role of Sequencing
    · Non-Blood Sampling
    · LDT Regulatory Picture
    · New Product Launches
    · Near-Patient Testing

    *Key Topics Covered:*
    One: Executive Summary

    Two: Introduction

    Three: The Global Picture For In Vitro Diagnostic Markets

    Four: Company And Industry Trends

    Five: Point-Of-Care Tests

    Six: The Core Lab

    Seven: Immunoassays

    Eight: Molecular Assays

    Nine: Hematology

    Ten: Coagulation

    Eleven: Microbiology And Virology

    Twelve: Blood Banking Services

    Thirteen: Histology And Cytology

    Fourteen: Company Profiles: The Top Tier

    Fifteen: Company Profiles: The Second Tier

    Sixteen: Company Profiles: Blood Bank Specialists

    Seventeen: Company Profiles: Coagulation Specialists

    Eighteen: Company Profiles: Core Lab And Other Companies

    Nineteen: Company Profiles: Ctc & Liquid Biopsy Test Providers

    Twenty: Diabetes Specialists

    Twenty-One: Company Profiles: Hematology (Cell Analysis) Specialists

    Twenty-Two: Company Profiles: Histopathology Specialists

    Twenty-Three: Company Profiles: Immunoassay Specialists

    Twenty-Four: Information Technology Specialists In In Vitro Diagnostics

    Twenty-Five: Company Profiles: Microbiology Specialists

    Twenty-Six: Company Profiles: Molecular Test Specialists

    Twenty-Seven: Company Profiles: Point Of Care Test Specialists

    Twenty-Eight: Company Profiles: Prenatal Test Service Providers

    Twenty-Nine: Company Profiles: Quality Control & Sample Pretreatment Specialists

    Thirty: Test Service Providers
    For more information about this report visit

    Laura Wood, Senior Manager
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: In Vitro Diagnostics Reported by GlobeNewswire 5 hours ago.

    0 0

    Dublin, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The "Dental Infection Control Products - Global Strategic Business Report" report has been added to *'s* offering.The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Dental Infection Control Products in US$ Thousand.

    *The report profiles 35 companies including many key and niche players such as:*

    · 3M (USA)
    · Air Techniques, Inc. (USA)
    · Biotrol (USA)
    · Coltne/Whaledent AG (Switzerland)
    · Crosstex International, Inc. (USA)
    · Dentisan (UK)
    · Dentsply Sirona, Inc. (USA)
    · First Medica (USA)
    · Hu-Friedy Mfg. Co., Inc. (USA)
    · KaVo Kerr Group (USA)
    · Laboratoire Septodont (France)
    · maxill, Inc. (Canada)
    · Owens & Minor, Inc. (USA)
    · Schlke & Mayr GmbH (Germany)

    *Key Topics Covered:*


    Study Reliability and Reporting Limitations
    Data Interpretation & Reporting Level
    Quantitative Techniques & Analytics
    Product Definitions and Scope of Study


    Dental Infection Control Products: Essential to Prevent Cross - Infections and Occupational Exposures to Pathogens in Dental Facilities
    Asia-Pacific to Spearhead Future Growth in Dental Infection Control Products Market
    Rising Significance of Infection Control in Dental Practices
    Noteworthy Trends and Issues
    Personal Protective Equipment: Protection against Infectious Material
    Gloves: The First Line of Defense in Dental Offices
    Low Latex Protein Gloves - A Solution to Address Latex-Related Allergies
    Powdered Vs Non-Powdered Gloves
    Ban on Use of Powdered Medical Gloves
    Mask - Another Critical Protective Wear to Prevent Spread of Infections
    Surface Cleaning & Disinfection: Vital for Infection Control in Dental Practices
    Comparing Alcohol-based and Non-Alcohol Based Disinfectants
    Go Green: Order of the Day
    Eco-Friendly Alternatives to Toxic Chemicals Gain Prominence
    Need to Achieve Eco-Friendliness Brings Newer Green Methods to the Fore
    Reusables & Disposables: Drawing a Parallel
    Advancing Dentistry Technologies Necessitate Greater Focus on Infection Control
    Stemming Tuberculosis Cases: Vital Role of Infection Control Practices in Dental Clinics
    Recent Incidents of Infections & Epidemics Present Infection Control Challenges for Dental Clinics
    Ebola Virus Disease: Implications for Dental Practices
    MERS Infection: Emphasis on Adopting Infection Control in Dental Practices
    Zika Virus Threat & Implications for Dentistry
    Infection Control in Dental Unit Water Lines
    Inadequate Cleaning of Surgical Equipment: High Risk for Patients
    Rising Cost of Infection Control: A Matter of Concern for Dental Practices
    Reading the Fine Print: Essential for Appropriate Usage of Products
    Bib Clips: Likely Risk of Infection
    Regulations Putting Global Dental Infection Control Market on the Fast Track
    A Peek into the Regulatory Framework for Dental Infection Control Products in the US


    Demographic Factors & Increased Spending on Oral Care to Fuel Growth in the Dental Market
    Changing Dynamics of Dental Markets in Developed & Developing Regions
    Consumables Dominate Sales of Dental Product Sales
    Increasing Healthcare Spending to Stir Demand for Dental Products & Services
    Rising Demand for Dental Treatments from Expanding Middle Class Population
    Aging Global Population: A Major Growth Propeller
    Transforming Role of Dental Practice
    Spurt in Dental Tourism Offers Growth Opportunities
    M&A Activity on the Rise in Dental Industry


    Why is Infection Control Necessary in Dental Practices?
    Common Transmission Modes of Microorganisms in Dental Practices
    Airborne Infections: High Risk in Dental Practices
    Diseases/Infections Caused by Certain Micro Organisms
    A Glance at Select Diseases/Infections in Dental Practice
    Infection Control in Dental Practices: An Introduction
    Dental Infection Control Products: A Brief Description of Select Products
    Personal Protective Products
    Types of Dental Gloves
    Protective Eyewear
    Tunics & Uniforms
    Rubber Dams
    How is Disinfection Different from Decontamination?
    Dental Tray Covers
    Sterilization Products


    5.1 Focus on Select Players

    5.2 Recent Industry Activity
    Young Innovations Takes Over Promident
    COLTENE to Take Over SciCan
    Young Innovations Acquires Mydent International
    Owens & Minor Acquires Surgical & Infection Prevention (S&IP) Business of Halyard Health
    Crosstex Launches Syclone Amalgam Separator
    CleanCert Unveils CleanCert+ Biofilm Disinfectant and LabCert for Dental Infection Control
    Crosstex Acquires SAFE-FLO Saliva Ejector Products from RJC Products
    Sri Trang Group Establishes Ventyv Company
    Hu-Friedy Takes Over J. Palmero Sales Company
    Cantel Medical Purchases Accutron
    Dentisan Launches Dentifloor
    Crosstex Acquires Sterilex Liquid Ultra Product Line



    7.1 The United States
    A. Market Analysis
    Increasing Focus on Infection Control
    Regulatory Guidelines for Dental Infection Control Prevention in the US
    Risk of Infection Transmission in Dental Surfaces
    California's Infection Control Guidelines for Dental Practices
    California Enacts New Legislation to Improve Infection Control Safety in Dental Practices
    Sterilization of Low-Speed Handpieces - Essential to Prevent Cross Contamination in Dental Offices
    Dental Market: Spending Levels on the Rise
    Dental Practices Focus on Patient-Centric Operations
    Digital Dentistry & Shift to Cloud: Technology Developments in Dental Market
    Rise of Group Practices Affects Solo Dental Establishments
    Healthcare Reforms & Dental Market
    B. Market Analytics

    7.2 Canada
    Market Analysis

    7.3 Japan
    Market Analysis

    7.4 Europe
    A. Market Analysis
    Market Overview
    Dental Market in Europe - Stable Growth Ahead
    European Dental Market Ripe for Consolidation
    B. Market Analytics

    7.4.1 France
    Market Analysis

    7.4.2 Germany
    Market Analysis

    7.4.3 Italy
    Market Analysis

    7.4.4 The United Kingdom
    A. Market Analysis
    Current and Future Analysis
    Dental Sterilization Standard
    B. Market Analytics

    7.4.5 Spain
    Market Analysis

    7.4.6 Russia
    Market Analysis

    7.4.7 Rest of Europe
    Market Analysis

    7.5 Asia-Pacific
    Market Analysis

    7.5.1 China
    Market Analysis

    7.5.2 India
    A. Market Analysis
    Market Overview
    Dental Market: An Overview
    B. Market Analytics

    7.5.3 Rest of Asia-Pacific
    Market Analysis

    7.6 Latin America
    A. Market Analysis
    Current and Future Analysis
    Focus on Select Dental Markets
    B. Market Analytics

    7.7 Rest of World
    Market Analysis


    Total Companies Profiled: 35 (including Divisions/Subsidiaries - 40)

    · The United States (22)
    · Canada (3)
    · Europe (14)

    · France (1)
    · Germany (5)
    · The United Kingdom (3)
    · Italy (2)
    · Rest of Europe (3)

    · Asia-Pacific (Excluding Japan) (1)

    For more information about this report visit

    Laura Wood, Senior Manager
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Infectious Disease Testing, Dental Reported by GlobeNewswire 5 hours ago.

    0 0

    The walking dead: Fossils on the move can distort patterns of mass extinctions Gainesville FL (SPX) Sep 18, 2018

    Using the fossil record to accurately estimate the timing and pace of past mass extinctions is no easy task, and a new study highlights how fossil evidence can produce a misleading picture if not interpreted with care. Florida Museum of Natural History researchers used a series of 130-foot cores drilled from the Po Plain in northeastern Italy to test a thought experiment: Imagine catastrop Reported by Terra Daily 3 hours ago.

    0 0

    A’ Design Award and Competition is Welcoming Submissions of Most Creative and Ingenious Architecture Design Projects by Architects, Architecture Offices, Real Estate Developers, Civil Engineers and Construction Agencies.

    COMO, Italy (PRWEB) September 19, 2018

    The A' Architecture, Building and Structure Design Award is an annual event that admits submission from all around the globe. Architecture design projects that were proposed and/or completed within the last 10 years are eligible to be nominated. The A' Worldwide Architecture Design Award and Competition is presented in several different sub-categories such as; residential architecture, commercial architecture, cultural architecture, institutional architecture and more.

    Once submissions are accepted, an international panel of professional jury members will judge the projects for both their technical content and their artistic creativity. Jury members will be looking forward to choose projects which have a capacity to influence architecture design professionals worldwide towards the creation of unparalleled and original designs. Entries to the A' Architecture, Building and Structure Design Award will be peer reviewed and voted against predefined evaluation criteria such as; innovation, ergonomics, flow design, public benefits, functionality, sustainability, creative approach and excellent use of space.

    Winners will be awarded with the A' International Design Awards’ original 3D printed metal trophy, excellence in architecture design certificate, immense PR campaign, hardcover yearbook of best projects and many other benefits such as exclusive invitation to the Award Ceremony and Exhibition, as well as inclusion in World Design Rankings and Best Designs of the World.

    Regular deadline for submissions is on September 30, 2018 and results of the A' Architecture, Building and Structure Design Award and Competition will be announced on April 15, 2019 through a large network of design oriented publications and media partners.

    About A' Architecture, Building and Structure Design Award
    The A' Architecture, Building and Structure Design Award, annually organised by A' Design Award and Competition, was esteablished to recognise distinguished Architecture design projects all around the world. The A' Architecture Design Award is aspired to create awareness for good architecture design practices and principles and is strongly committed to the idea of supporting creativity and competence in architecture design by promoting best design projects worldwide throughout a wide network of media partners. Interested parties may find more details on the accolade at Reported by PRWeb 4 hours ago.

    0 0

    Enteral Feeding Devices Market By Product, By End-use, Regional Outlook (U.S., Canada, Germany, France, UK, Spain, Italy, India, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa), Application Potential, Competitive Market Share & Forecast, 2018 – 2024

    Sellbyville, Delaware, Sept. 19, 2018 (GLOBE NEWSWIRE) --Global Enteral Feeding Devices Market will surpass USD 3.5 billion by 2024; according to a new research report by Global Market Insights, Inc. Growing burden of gastrointestinal diseases and cancer will impact industry growth positively in the forthcoming years. Mostly the geriatric population suffers from gastrointestinal diseases such as irritable bowel syndrome, and gastroesophageal reflux disease that escalates the demand for enteral feeding devices impacting enteral feeding devices industry growth positively over forthcoming years. Moreover, in India, every year around 0.7 million women get diagnosed with cancer that will increase the demand for enteral feeding devices in future.

    Enteral feeding devices market growth should be further driven by technological advancements incorporated within enteral feeding devices. Improvised quality of enteral devices and innovations will increase its adoption rate among the developed countries such as UK and Germany having high per capita income thereby augmenting business growth. However, difficulties related to enteral feeding devices may restrain the market growth in future.

    *Request for a sample of this research report @ *

    Nasogastric tube segment was valued at USD 240.5 million in 2017 owing to the high preference of nasogastric tubes for short term tube fed enteral nutrition. Home enteral nutrition sector growth, growing number of accident cases wherein patients require nutritional supply for short term will drive nasogastric tube segmental growth over the forecast period.

    Hospitals segment of enteral feeding devices market will grow at 6.0% over the forecast timeframe. High adoption rate by hospitals for enteral feeding devices will drive the segmental growth. Also, increasing number of in-patient surgeries will positively impact the business growth. According to The Statistic Portal, in 2016, there were around 5,534 hospitals and the increasing prevalence of chronic disorders should impel the segmental growth.

    Browse key industry insights spread across 173 pages with 114 market data tables & 9 figures & charts from the report, *“Enteral Feeding Devices Market”* in detail along with the table of contents:

    U.S. enteral feeding devices market accounted for 81.0% regional revenue share in 2017. Rising incidence of chronic diseases and technological advancement will augment adoption rate of enteral feeding devices thereby, should boost industry growth over the estimated timeframe.

     India enteral feeding devices industry will grow at 7.1% over the coming years and this can be accounted to several factors including growing geriatric population, rising prevalence of chronic diseases and malnourishment issues in under developed cities. In India, there are around 190.7 million people that suffer from malnutrition thereby, should propel enteral feeding devices market growth.

     Some of the prominent industry players actively manufacturing enteral feeding devices include ALCOR Scientific, Abbott Nutrition, Amsino International, Applied Medical Technologies, Baxter International, B. Braun Melsungen, Becton Dickinson, Boston Scientific, Cardinal Health, Cook Medical, ConMed, Danone, Degania Silicone, Fresenius Kabi, Halyard Health, Moog, Nestle, and Vygon.

     Key industry players will focus their efforts on R&D and adopt strategic initiatives that will help them to maintain their brand and market share. For instance, in July 2014, Vygon presented its product MIC and MIC-key introducer kit for enteral feeding over conventional practices that has developed its product portfolio rendering it with competitive advantage.

    *Make an inquiry for purchasing this report @*

    *Browse Related Reports:*

    · *Gastrostomy Tube Feeding Devices Market Size 2018 – 2024*

    Gastrostomy Tube Feeding Devices Market revenue is poised to see significant growth from 2018 to 2024. Increasing prevalence of chronic diseases such as cancer, diabetes, respiratory & gastrointestinal disorders, cardiovascular diseases and neurological disorders resulting into malnutrition will further fuel industry expansion.

    · *Kidney Stones Management Market Size 2018 – 2024*

    Global Kidney Stones Management Market revenue was at over USD 1,649 Million in 2017, with growth forecast over 4.1% CAGR from 2018 to 2024, owing to increasing prevalence and recurrence rate of kidney stones globally.

    *About Global Market Insights*

    Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

    CONTACT: Contact Us:
    Arun Hegde
    Corporate Sales, USA
    Global Market Insights, Inc.
    Phone: 1-302-846-7766
    Toll Free: 1-888-689-0688
    Blog: Reported by GlobeNewswire 4 hours ago.

    0 0

    Italy’s new populist government has until Sept. 27 to make a difficult decision: How to reconcile its expensive election promises with the reality of the country’s fragile finances. Reported by Wall Street Journal 2 hours ago.

    0 0

    Ronaldo desperate to help Juventus end Champions League hoodoo SHERIDAN BIRD IN ITALY: To get their hands back on the cup, they enlisted the man who has dominated the tournament over the last decade. Signing Ronaldo was a masterstroke. Reported by MailOnline 3 hours ago.

    0 0

    Dublin, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The "Heterogeneous Networks (HetNets) - Global Strategic Business Report" report has been added to *'s* offering.This report analyzes the worldwide markets for Heterogeneous Networks (HetNets) in US$ Million for major Geographic Regions including the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2024.

    *End-Use Sectors analyzed for the Global market in terms of Annual Installations of *· Small Cells (Femtocells, Picocells, Microcells, and Metrocells)
    · Residential and Non-Residential (Urban, Rural/Remote, and Enterprise)

    *Architectures analyzed for the Global market in terms of Annual Installations of Small Cells in Non-Residential Sector include *· All-In-One
    · Virtualized Controller
    · Distributed Radio Unit
    · Small Cell with DAS

    *The report profiles 39 companies including many key and niche players such as:*

    · AirHop Communications, Inc. (USA)
    · Airspan Networks Inc. (USA)
    · Alcatel-Lucent Enterprise (France)
    · American Tower Corp. (USA)
    · Aricent Group (USA)
    · AT&T Inc. (USA)
    · Cambridge Broadband Networks Limited (UK)
    · Ceragon Networks Ltd. (Israel)
    · Cisco Systems, Inc. (USA)
    · CommScope Inc. (USA)
    · Airvana LP (USA)
    · Huawei Technologies Co. Ltd. (China)
    · ip.access Limited (UK)
    · Mobilitie, LLC (USA)
    · NEC Corporation (Japan)
    · Nokia Networks (Finland)
    · NXP Semiconductors N.V. (The Netherlands)
    · Qualcomm Incorporated (USA)
    · Qucell, Inc. (USA)
    · RadiSys Corporation (USA)
    · Ruckus Networks (USA)
    · Samsung Networks Business (South Korea)
    · SpiderCloud Wireless, Inc. (USA)
    · Telefonaktiebolaget L. M. Ericsson (Sweden)
    · ZTE Corporation (China)

    *Key Topics Covered:


    Study Reliability and Reporting Limitations
    Data Interpretation
    Quantitative Techniques & Analytics
    Product Definitions and Scope of Study


    Heterogeneous Network (HetNet): Enabling Seamless Movement between Wi-Fi, DAS, Small Cells and Mobile Networks
    Figure: The HetNet Continuum
    Myriad Advantages Offered by HetNet Solutions Drive Steady Market Evolution
    Rising User Expectations of QoE & QoS: Foundation for Carrier HetNet Deployment
    HetNets Approach Resolves Network Coverage Gaps & Capacity Shortage
    HetNet Undergoes Transformation with Increasing Number of Solution Offerings
    Surge in Mobile Data Traffic: The Fundamental Factor Driving HetNet Deployments
    Proliferation of Smartphones Lead to Escalation in Mobile Data Traffic
    Emerging IoT to Widen the Demand for Mobile Data
    Increase in Mobile-Data Traffics Makes Deployment of Distributed Networks Inevitable
    Global Market Outlook


    The Critical Role of Small Cells in Continuity of 4G and Evolution of 5G Drive Strong Growth for Heterogeneous Networks
    Small Cells to Become Building Blocks of 5G Networks
    Why Network Densification Using Small Cells is Necessary for 5G?
    Role of Small Cells in 5G Revolution
    Small Cells: The Most Appealing and Cost-Effective Option
    Small Cells and Commercial-Scale Implementation of 5G: Current Status
    Development and Growth of the Fifth Generation (5G) Wireless Network
    Global Small Cell Deployments: Facts & Figures
    The Global Small Cell Market Trends Summarized
    Increased Small Cell Deployments Anticipated for Densification of LTE Networks
    Mitigating Interference Problems in HetNets with Small Cells: Various Techniques
    Carrier Aggregation along with Cross Carrier Scheduling
    Coordinated-Multipoint (CoMP)
    Approaches to Deal with 5G Backhaul Network Challenges
    Machine Learning, Fuzzy Neural Network, and Bio-inspired Algorithms to Find Increasing Adoption in HetNets
    Taxonomy of AI-Based SON Techniques in HetNets
    Machine Learning (ML)
    Genetic Algorithms
    Future Challenges
    Optimization of Data Center Virtual Resource for Cloud-Based HetNets
    Utilization of Software-Defined Network (SDN) Intelligence in 5G HetNets
    Distributed Edge Intelligence in Hetnets
    Global Rollout of LTE Infrastructure: A Major Factor Boosting Prospects for HetNets
    HetNet Implementation, from the Perspective of LTE and LTE-A: Key Considerations
    Cloud Phenomenon to Further Fuel Wireless Traffic
    Small Cells-as-a-Service (SCaaS): An Apt Solution for Saving Manpower and Money
    High Costs Deters Cloud RAN Deployment in HetNets
    Figure: Cloud RAN Architecture
    Mobile Backhaul Critical to Address Requirements of Transforming Mobile Connectivity Landscape
    Intelsat Unveils New Newtec Dialog Integrated IntelsatOne 2G Platform
    Advancements in Microwave to Help Address 5G Backhaul Requirements
    Pre 5G - Enhanced Fixed Wireless Access
    SON-Enabled HetNets Ideal for Smooth Integration and Interworking of Diverse Communication Technologies
    Figure: HetNets Support Multi-dimensional Telecom Network
    SON Software: A Key Enabler in HetNet Implementation
    Wi-Fi Offload Assumes Growing Role in HetNet Architecture
    Wi-Fi Integrated Small Cells Devices: A Potential Game Changer
    HetNets: A Key Benefactor and Enabler of Eco-friendly Green Radios'
    Software Defined Networking (SDN): A Potent Approach for Backhaul Applications in HetNets
    Convergence of Information and Communications Spawns Plethora of Connected Devices
    Figure: Telecommunications Network Convergence
    Heterogeneous Networks Suitable for Delivery of M2M Applications and Services
    Urban Network Congestion Strengthens Case for HetNets
    Smart Small Cell Backhaul Strategy Critical for Smooth Operation of HetNets
    Smart Backhauling: A Tool for Honing Competitive Edge of Carriers
    Backhauling Vital for Sustaining Service Profitability
    Small Cell Backhaul Presents Number of Challenges
    SoC Development Essential for Mass Deployment of HetNets
    Security Gateway Solutions Required to Keep Pace with Expansion of HetNets


    5G Heterogeneous Network (5G HetNets)
    Service Management in Next Generation HWN
    Innovative Platform for Enterprise Connectivity
    Multi-Technology Small Cells
    Novel Strategy for Switching Networks in Dense HetNets
    Small Cell/Drone Integration Enables Various Applications
    Faster 4.5G Networks for Drones Flight
    An Innovative Collection of Easy-to Install, Plug and Play Small Cells
    NOMA Technique in Large, Hybrid HetNets
    More Efficient Backhaul-Solutions for Mobile Networks of the Future
    New Site to Overcome Small Cell Site Issues
    AirDensity Indoor UE Relay


    HetNets: A Prelude
    Figure: Typical HetNet Architecture
    Components of HetNet
    Technical Specifications of HetNet Base Stations in a Nutshell
    Small Cells
    Classification of Small Cells Based on Deployment Site
    Major Milestones in the Evolution of Small Cell Market
    Distributed Antenna System (DAS)
    Relay Nodes
    Wi-Fi Access Points
    Technologies Supporting HetNet Deployment
    Self-Organizing Network (SON)
    Mobility Management and Traffic Steering
    Coordinated multi-point (CoMP)
    Voice over LTE (VoLTE)
    Major Industry Associations
    Small Cells Forum
    Network Vendors Interoperability Testing (NVIOT) Forum
    3GPP (3rd Generation Partnership Project)
    European Telecommunications Standards Institute (ETSI)
    Distinct Attributes of HetNet
    Architectural Changes
    Self-Organizing Networks (SON)
    Deployment Model
    Challenges to Service Management of HetNets
    Service Modeling
    SON Capabilities
    On Demand Management
    Converged Network Management
    Integration of 3GPP RAN with Non-3GPP RAN


    The HetNet Vendor Ecosystem
    Figure: HetNet Vendor Ecosystem
    Nokia Rides High on Small Cell Demand
    Nokia Benefits from Technical Proficiency
    Leading Suppliers of Small Cell Chipsets Summarized
    New Market Niches for Specialist Vendors Supplying Small Cells
    Leading RAN Vendors Enter the Small Cell Arena
    Operators Focus on Small Cell Installations


    Telstra Launches Telstra 4GX-lite Mobile Satellite Small Cell
    Qualcomm Introduces 5G NR Solution for Small Cells and Remote Radio Heads
    CCS Completes the Next-Generation Small Cell Network in London
    Qualcomm Introduces New LTE-IoT Features on the Qualcomm FSM Small Cell Platform
    Nokia Launches MulteFire(TM) Small Cell
    Sprint Launches New Small Cell Solution - SpiderCloud
    Samsung Unveils New Small Cell Portfolio
    Ericsson Launches Three Scalable Small Cell Solutions
    Sprint Unveils Sprint Magic Box
    SpiderCloud Wireless Announces Frequency Agile Small Cell

    Charter to Expand LTE Small Cell Trials in US
    Rogers to Deploy Thousands of Small Cells for 5G
    Boingo Deploys Private LTE Cellular Network on 3.5 GHz CBRS Band
    Metro Transit Partners with T-Mobile US to Install Wireless Equipment inside Metro Tunnels
    Comba Telecom Partners with CAV to Construct In-Building Wireless Networks for Proscenium
    M1 Partners with Nokia to Test the Use of 5G Small Cells
    O2 and Arqiva to Deploy 300 Small Cells across London
    Telstra to Deploy 1,000 Small Cells in Metro
    ZTE and China Unicom Announces the Commercialization of ZTE Magic Pole Small Cell Solution
    Fujitsu Partners with Ceragon to Sell Wireless Backhaul Solutions
    Sprint Enters into a Multi-Year Business Partnership with Cox Communications
    ARRIS Acquires Ruckus Wireless and ICX Switch Business from Broadcom
    Altran Group Acquires Aricent
    Qualcomm to Collaborate with ITRI on 5G NR-enabled Small Cell Technologies
    Corning Acquires SpiderCloud
    Cisco Exits Small Cell Business
    Nokia Unveils a New Way of Deploying Small Cells
    QuadGen Partners with SpiderCloud to Offer Small Cell Solutions
    Reliance Jio and AirHop Announces the Deployment of JioSON Powered by AirHop's eSON360
    Airspan Announces the Integration of Airspan's Small Cells into the Reliance Jio
    Altiostar Collaborates with Dali Wireless for virtual RAN Technology



    A. Market Analysis
    Smart Devices and Data Hungry LTE Supported Services Fuel Growth of Small Cell Networks
    Mobile Network Operators Embrace Small Cells to Deal with Densification
    Small Cell Technology Set to Fast-Track Broadband Connectivity of Chattanooga
    FCC Decision to Speed-Up Small Cell Deployments Paves the Way for 5G Preparedness
    Small Cells and its Role in 5G
    Significance of FCC Decision for Resolving Regulatory Barriers
    Recent Developments by Major Providers to Strengthen 5G Services
    Small Cells Paves the Way for Extending High-Speed Wireless Connectivity to Rural Regions
    The Future of Rural Small Cells
    Fixed Wireless
    Virtual FttF
    B. Market Analytics

    8.2 JAPAN
    Market Analysis

    8.3 EUROPE
    A. Market Analysis
    Need to Optimize Networks for Data Traffic Drives Growth in the World's Largest HetNets Market
    Booming Small Cells Market Becomes a Platform for New Services
    Russian Femtocell Market: A Late Bloomer
    B. Market Analytics

    A. Market Analysis
    Asian MNOs to Remain at the Forefront of Network Densification, Bodes Well for Market Growth
    Considerations to Achieve Desirable Progress
    Telecom Major, Reliance Jio, Makes India a Potential Laden Market for Small Cells
    HetNets and Small Cells in India: An Overview
    Small Cells Related Trends Summarized
    B. Market Analytics

    A. Market Analysis
    African Market: An Emerging Hotbed for Small Cells
    B. Market Analytics

    9. COMPANY PROFILESTotal Companies Profiled: 39 The United States (17)

    · Japan (2)
    · Europe (11)

    · France (2)
    · The United Kingdom (3)
    · Italy (1)
    · Rest of Europe (5)

    · Asia-Pacific (Excluding Japan) (7)
    · Middle East (2)

    For more information about this report visit

    Laura Wood, Senior Manager
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Telecommunications and Networks, Networks Reported by GlobeNewswire 3 hours ago.

    0 0

    Dublin, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The "Biosimilars - Global Strategic Business Report" report has been added to *'s* offering.

    The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. This report analyzes the worldwide markets for Biosimilars in US$ Million.

    *The report profiles 71 companies including many key and niche players such as:*

    · Allergan Plc (Ireland)
    · Amgen, Inc. (USA)
    · Biocon Ltd. (India)
    · Biopartners GmbH (Switzerland)
    · Boehringer Ingelheim International GmbH (Germany)
    · Celltrion, Inc. (South Korea)
    · Dr. Reddy's Laboratories Ltd. (India)
    · Eli Lilly and Company (USA)
    · Fresenius Kabi (Germany)
    · Intas Pharmaceuticals Ltd. (India)
    · Mylan N.V. (USA)
    · Pfizer, Inc. (USA)
    · Samsung Bioepis Co., Ltd. (Korea)
    · Sandoz International GmbH (Germany)
    · STADA Arzneimittel AG (Germany)
    · Teva Pharmaceutical Industries Ltd. (Israel)

    Study Reliability and Reporting Limitations
    Data Interpretation & Reporting Level
    Quantitative Techniques & Analytics
    Product Definitions and Scope of Study

    Biosimilars: An Introductory Prelude
    World Healthcare Sector Gears Up for Biosimilar Wave
    Biosimilars Offer Great Promise Despite Challenges
    The US & Europe Drive Momentum in Worldwide Biosimilars Sales
    Emerging Markets also Offer Robust Growth Opportunities
    R&D Funding: Crucial for Future Expansion of Biosimilars Market
    Prevailing Economic Scenario Favors Funding Pattern

    Slew of Product Approvals Scale Up Market Revenues
    Biosimilar Approvals in Europe (as of H1 2018)
    Biosimilar Approvals in the US (as of H1 2018)
    Pipeline Biosimilar Products in the US (as of H1 2018)
    Biosimilar Approvals in South Korea (as of H1 2018)
    Patent Expiry of Major Biopharmaceutical Drugs Leads Way for Biosimilars
    Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
    Cost Containment Measures Put Focus on Biosimilars
    High Cost of Biologics - Favorable for Biosimilars
    Efforts to Push Up Biosimilar Adoption Aid Market Expansion
    Increasing Share of Biotech Drugs to Drive Biosimilars Market
    Progressive Regulatory Framework Accelerates Product Approvals & Subsequently Market Revenues
    Specific Guidelines for Biosimilars in Various Countries with Year of Publication
    Biosimilars Regulatory Agencies in Select Regional Markets
    Improvement in Nomenclature & Interchangeability Enhance Appeal & Image of Biosimilars
    Human Insulin Biosimilars Eye Potential Opportunities
    Monoclonal Antibodies - A Key Segment for Biosimilars
    Approved Monoclonal Antibodies (2014-2017)
    Rituximab Biosimilars to Proliferate the Market
    Growing Incidence of Chronic Diseases & Ageing Population Widen Prospects for Biosimilars
    Growing Biosimilars Market - A Clear Advantage for Bioseparation Technologies
    Growth Restraints
    Lack of Uniform Regulations
    High Lead-time
    High Manufacturing Costs
    Difficulties in Delivery & Commercialization
    Automatic Substitution
    Biobetters: A Potential Industry Challenge
    Other Impediments to Market Acceptance

    Biological Drugs: An Introduction
    Biosimilars: Overview
    Characteristics of Biosimilars
    Development Cycle of Biosimilars
    Industry Participants

    Leading Players in the World Biosimilars Market
    Indian & Chinese Companies Seek Opportunities
    Increased Penetration of Biosimilars - Implications for Manufacturers
    Comparison of Entry Barriers for Biogenerics in Select Global Markets
    Vendors Emphasize Novel Strategies to Stay Competitive
    Licensing Deals and Development & Commercialization Partnerships Find Favor
    Select Biosimilar Licensing Deals & Collaborations Announced in the Recent Past
    Contract Manufacturing Gains Traction

    5.1 Focus on Select Global Players

    5.2 Product Approvals/Introductions
    Pfizer Bags FDA Approval for NIVESTYM
    Pfizer Wins FDA Approval for Retacrit Biosimilar Epoetin Alfa
    Amgen Achieves Top-Line Results for infliximab Biosimilar in Phase 3 Study
    Mylan Receives FDA Approval for Fulphila
    Apobiologix Wins Health Canada Approval for Lapelga Biosimilar
    Mylan Wins Marketing Authorization for Semglee Biosimilar Insulin Glargine in Europe
    Amgen Receives CHMP Positive Opinion for ABP 980 Trastuzumab Biosimilar
    Celltrion Bags European Approval for Herzuma Trastuzumab Biosimilar
    Amgen and Allergan Receive European Marketing Authorization for MVASI Biosimilar Bevacizumab
    Intas Pharmaceuticals Launches Pelgraz Pegfilgrastim Biosimilar in Europe
    Mabion Receives EMA Review Acceptance for MabionCD20
    Pfizer Receives EC Approval for TRAZIMERA
    Sandoz Bags Marketing Authorization for Hyrimoz in Europe
    Mylan and Fujifilm Receive CHMP Positive Opinion for Hulio Adalimumab Biosimilar
    Dr. Reddy's Introduces Hervycta in India
    Celltrion Receives FDA Approval for BLA Review for CT-P6 mAb Biosimilar
    Celltrion Receives FDA BLA Review Acceptance for CT-P10 mAb Biosimilar
    Merck Rolls Out RENFLEXIS infliximab-abda in the US
    Pfizer Receives FDA Approval for IXIFI Monoclonal Antibody
    Mylan Wins FDA Approval for Ogivri
    Samsung Bioepis Wins Marketing Authorization for ONTRUZANT in Europe
    Fresenius Kabi Submits Marketing Authorization Application for MSB11022 in Europe
    Sandoz Bags European Approval for Erelzi to Treat Mutiple Immunological Diseases
    Fujifilm Kyowa Kirin Receives EMA's MAA Review Acceptance for FKB327 Biosimilar
    Celltrion Bags EMA Approval for Truxima Biosimilar mAb
    Biocon Introduces KRABEVA in India
    Mylan Receives Brazilian Approval for Biosimilar Trastuzumab
    Celltrion Submits Sales Approval Application for Herzuma in Japan

    5.3 Recent Industry Activity
    Biogen Acquires Additional Stake in Samsung Bioepis
    AbbVie and Mylan Ink Patent License Agreement for HUMIRA
    Amneal Pharmaceuticals and Impax Laboratories Merge
    Amneal Signs Licensing Agreement with mAbxience for Bevacizumab Biosimilar
    Valerius Biopharma Teams Up with Catalent Pharma for Biosimilars Production
    Fresenius Kabi Expands Operations in Runcorn
    STADA to Acquire Additional Stake in BIOCEUTICALS Arzneimittel
    Biocon and Sandoz Ink Global Partnership Deal
    Eli Lilly Partneres with Cipla to Market Basaglar in India
    Cipla to Discontinue to In-House Production of Biosimilar Drugs
    Merck Divests Biosimilars Business to Fresenius
    Nidda Healthcare Holding Acquires STADA Arzneimittel
    Amgen and Simcere to Co-develop and Commercialize New Biosimilars in China
    Aurobindo Pharma Acquires Four Biosimilar Products from TL Biopharmaceutical



    7.1 The United States
    A. Market Analysis
    Spectacular Rise on the Cards
    Latest Developments in the Biosimilars Space
    Challenges in the US Drug Approval Pathway for Biosimilars
    Critical Requirements for Marketing Approval
    Need to Cut Down Prices for Increased Adoption
    B. Market Analytics

    7.2 Japan
    Market Analysis

    7.3 Europe
    A. Market Analysis
    Europe: The Foremost Propagator of Biosimilars
    Europe Stays Ahead in the Biosimilars Race
    Segment-Wise Analysis
    Payers Eye Biosimilars to Curtail Costs
    Biosimilar Pricing Competition to Intensify Further
    Biosimilars Regulatory Framework: Well-Established
    Biosimilar Regulatory Timeline from Legislation to Approval in the EU
    Further Clarity Needed Regarding Extrapolation of Biosimilars for Multiple Indications
    Challenges Ahead
    Heavy Investment and Regulations
    Complex Production Process
    B. Market Analytics

    7.3.1 France
    Market Analysis

    7.3.2 Germany
    Market Analysis

    7.3.3 Italy
    Market Analysis

    7.3.4 The United Kingdom
    A. Market Analysis
    Nascent UK Biosimilars Market
    NICE's Latest Ruling Bodes Well for Biosimilars
    B. Market Analytics

    7.3.5 Spain
    Market Analysis

    7.3.6 Rest of Europe
    A. Market Analysis
    Biosimilar-related Developments in Russia
    B. Market Analytics

    7.4 Rest of World
    A. Market Analysis
    Asia-Pacific: Market Laden with Opportunities
    High Costs of Biologics Grant Edge to Biosimilars
    Biosimilars Evolve into a Niceh Segment within the Thriving Indian Biopharma Industry
    Collaborations with Western Counterparts in Biosimilar Development
    Guidelines for Biosimilars in India
    New Guidelines to Underpin Sales Growth
    Asia-Pacific: Regulatory Framework
    Latin America
    The Middle East and North Africa
    Sub-Saharan Africa
    Biosimilars Set to Register Gains in Canada
    Future Scenario
    Regulatory Framework
    B. Market Analytics


    Total Companies Profiled: 71 (including Divisions/Subsidiaries - 77)

    · The United States (15)
    · Canada (1)
    · Japan (3)
    · Europe (26)

    · France (1)
    · Germany (8)
    · The United Kingdom (5)
    · Spain (1)
    · Rest of Europe (11)

    · Asia-Pacific (Excluding Japan) (29)
    · Middle East (2)
    · Latin America (1)For more information about this report visit

    Laura Wood, Senior Manager
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Biosimilars and Biosuperiors Reported by GlobeNewswire 3 hours ago.

    0 0

    Dublin, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The "Global Cosmeceuticals Market Outlook 2022" report has been added to *'s* offering.
    Global Cosmeceuticals Market Outlook 2022, provides an insight into the current and future prospective of this market. This report covers the major trends and drivers and their impact on the market. The report also discusses some of the restraints that can hinder the growth of the market.The advent of cosmeceuticals has revolutionized the Cosmetic and Personal Care Industry. These beauty products have the ability to resolve the cause of imperfections rather than covering them. Due to this ability, the share of cosmeceuticals is incessantly increasing in the Cosmetic and Personal Care Industry. It is anticipated that the global cosmeceuticals market will reach US$ 72.2 Billion by 2022. The growth of the market is majorly driven by rising desire of people to maintain healthy skin without using chemicals. The common ingredients used in the preparation of cosmeceuticals are investigated in detail report.The major application areas of cosmeceuticals include skin care, hair care, and injectables. Skin care is the largest application area of cosmeceuticals followed by hair care. In skin care, market anti-aging products accounts for the largest share. This large share can be attributed to rising desire among 35+ age group people to have a youthful skin. The injectables market is expected to witness the highest growth from 2018-2022. This growth is likely to be driven by incessant launch of new and improved injectables, such as solid HA fillers, in the market. The report provides current and forecasted market for each of the application areas of cosmeceuticals.

    Moreover, the report also contains the markets for the major regions, including North America, Europe, Asia Pacific, and Rest of the World. Asia Pacific is the largest market and is also expected to witness the highest growth. The major reasons for the high growth are the rising disposable income of this region coupled with the increasing appearance consciousness among people. North America and Europe are expected to grow at a modest rate due to launch of new and innovative products in these market. The report also provides market sizes for the major countries including the US, Germany, France, UK, Italy, Spain, China, Japan, and India.

    *Key Topics Covered:*

    *1. Analyst View*

    *2. Research Methodology*

    *3. Global Cosmeceuticals Overview*
    3.1 Cosmeceuticals Ingredients
    3.1.1 Antioxidants
    3.1.2 Enzymes
    3.1.3 Proteins and Peptides
    3.1.4 Botanical Actives
    3.1.5 Other Cosmeceuticals Chemicals

    *4. Market Dynamics*
    4.1 Market Drivers
    4.1.1 Ageing Population and Increasing Consumer Awareness
    4.1.2 Adoption and Affordability of Cosmeceuticals in Emerging Economies
    4.1.3 Growing Demand for Natural Ingredients
    4.1.4 Emerging Need for Multi-Functional Products
    4.2 Market Restraints
    4.2.1 Lax Regulations
    4.2.2 High Cost of Branded Cosmeceuticals
    4.2.3 Impact of Global Economic Downturn on Premium Products
    4.3 Market Trend
    4.3.1 Consumers Opting for Sustainable Products
    4.3.2 Nano Technology Boosting the Anti-Aging Skin Care Market
    4.3.3 Growing Mergers and Acquisitions
    4.3.4 Digital Marketing: Gaining Momentum
    4.3.5 Rising Focus towards Male Grooming Products

    *5. Global Cosmeceuticals Market Outlook to 2022*

    *6. Market by Segment*
    6.1 Skin Care
    6.1.1 Anti-Aging
    6.1.2 Skin Whitening
    6.1.3 Sun Care
    6.1.4 Professional Skin Care
    6.1.5 Acne Care
    6.1.6 Others
    6.2 Hair Care
    6.2.1 Hair Growth Products
    6.2.2 Anti-Dandruff Products
    6.2.3 Others
    6.3 Injectable
    6.3.1 Botulinum Toxin-Based Injectable Cosmeceuticals
    6.3.2 Dermal Fillers
    6.3.3 Others
    6.4 Others Cosmeceuticals Products
    6.4.1 Lip Care
    6.4.2 Tooth Whitening
    6.4.3 Anti-Cellulite/Body Slimming Preparations
    6.4.4 Others

    *7. Market by Region*

    *8. Competitive Landscape*
    8.1 Croda International Plc
    8.2 Johnson & Johnson
    8.3 L'Oreal
    8.4 Procter & Gamble
    8.5 Avon
    8.6 Shiseido
    8.7 Beiersdorf
    8.8 Elementis8.9 Unilever
    For more information about this report visit

    Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

    Laura Wood, Senior Manager
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Cosmetics Reported by GlobeNewswire 3 hours ago.

    0 0

    Italian Deputy Prime Minister and 5-Star Movement leader Luigi Di Maio said on Wednesday he had "full confidence" in Economy Minister Giovanni Tria after local media reports about Tria's possible resignation. Reported by Reuters India 2 hours ago.

    0 0

    Chief Analyst at Danske Bank Christin Tuxen expects the pair to climb to the 1.25 area within a year’s view.

    *Key Quotes*

    “Downside risks from worries over Italian fiscal sustainability now seem much more limited near term (see next page) but we still think the relative-rate support to the USD versus the *EUR*, together with the lingering trade war, will be prone to deliver pockets of USD strength in the autumn. This should leave EUR/USD in a range around 1.15 on a 3M horizon but the relative cyclical picture may be shifting in favour of the euro area towards year-end and hold a hand under the pair, possibly supported by relative equity flows. However, medium term, the euro capital outflows of recent years will fade as the first ECB hike draws closer. Alongside valuation, this is set to support EUR/USD in 6-12M”.

    “We have lifted our near-term profile a little, as we see less potential for Italy to weigh in H2 and now see EUR/USD at 1.15 in 1M, 1.15 (previously 1.13) in 3M, 1.18 (unchanged) in 6M and 1.25 (unchanged) in 12M”. Reported by 3 hours ago.

    0 0

    Italy's most successful team are about to become a lot more popular worldwide thanks to the signing of the five-time Ballon d'Or winner Reported by 2 hours ago.

    0 0

    India’s plan to modernise the highways network requires billions of dollars of investment but the worst bad-loan ratio after Italy among the world’s 20 largest economies has led bankers to shy away from this sector. Reported by IndiaTimes 2 hours ago.

    0 0

    Italy's current account surplus for July grew from the same period last year, largely due to an improvement in the services surplus, figures from the Bank of Italy showed Wednesday. The current account surplus increased to EUR 8.607 billion from EUR 7.864 billion a year ago. Reported by RTTNews 2 hours ago.

    0 0

    Wednesday 19 September, 2018A third of foreign countries download UK based websites quicker than UK residents and it could be costing UK business billions of pounds’ a year in lost revenue…..

    Travel website analysed 5.5 million interactions on their website over a 3-year period and found that out of the 80 countries that regularly visited their site, 26 downloaded the content quicker than UK visitors. This is despite the fact that the Holidaysplease website is hosted in Manchester.

    10 countries actually managed to download the content in half the time of UK visitors. These included countries such as Bulgaria, Hungary, Ukraine and Malta. The 26 countries that were quicker than the UK were on average 1,300 miles away from the UK.

    Commenting on the statistics, Charles Duncombe, director of said:

    “I was curious to see how quickly our site was being downloaded and so I used Google’s analytics software to see. I was shocked to see that UK visitor viewing speeds we only 27th out of 80 countries which is ridiculous when our website is hosted in the UK. How can someone who lives a few miles from where our website is hosted, see the same webpage later than someone who lives thousands of miles away? It just shows how there are still severe internet black spots in the UK that need to be addressed.”

    Research has shown that every extra second a website takes to download as many as 7% of people will abandon their visit.* With UK visitors having to wait 2 seconds longer than the countries that featured in the top 10 it could mean that 14% more UK visitors are abandoning their visit ahead of time. With £236bn of business being conducted online in the UK every year** that could mean as much as £33bn is being lost each year due to slower internet speeds.


    For further information contact: Fern Share or Charles Duncombe on 0121 200 5714 or at

    About Holidaysplease:

    Set up in 2002 is a luxury online holiday company. It has picked up over 30 industry awards including Online Travel Agency Of the Year 2017-18.

    Their 100+ strong team advise customers on the best places to stay in the world.

    Statistics from 5.5m page downloads on 2015-2018:



    Avg. Page Load Time (seconds)





















































    Isle of Man



























    United Kingdom
























    Saudi Arabia






    New Zealand

































    Hong Kong



    United States






    United Arab Emirates


















    Trinidad & Tobago












    South Korea


















    Sri Lanka












    South Africa









    Antigua & Barbuda





















    * 365 retail survey:

    ** Office for National Statistics:

    * For more information regarding media usage, ownership and rights please contact Holidaysplease.

    Distributed by Reported by Pressat 1 hour ago.

older | 1 | .... | 1015 | 1016 | (Page 1017) | 1018 | 1019 | .... | 1077 | newer